Table 2.
PAROXYSMAL AF | PERSISTENT AF | p-Value | |
---|---|---|---|
CFAE as percentage of total LA surface area
| |||
AF | 19±9% | 27±4%* | 0.01 |
SR | 19±6% | 21±7%* | 0.55 |
CSp | 14±5% | 21±12% | 0.16 |
| |||
Overlap between CFAE in different rhythms as percentage of total LA surface
| |||
AF and SR | 3+/−1% | 4+/−2% | 0.09 |
AF and CSp | 1+/−1% | 5+/−2% | <0.001 |
SR and CSp | 4+/−2% | 6+/−2% | 0.16 |
| |||
CFAE regions in AF also fractionated in SR and CSp
| |||
SR | 16+/−4% | 15+/−5%% | 0.93 |
CSp | 6+/−3% | 18/−7% | <0.001 |
In patients with PsAF, there is a significantly higher extent of continuous CFAE sites in AF versus the extent of fractionated LA surface in sinus rhythm (CFAE at 27+/−4% of the total LA surface vs. fractionation at 21+/−7% during sinus rhythm, p=0.048).